These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
53 related items for PubMed ID: 194624
1. [Use of specific angiotensin inhibitors in the study of hormone-receptor interaction]. Myshlyakova NV, Indulen YuI, Klusha VE, Chipens GI. Biokhimiia; 1976 Jul; 41(6):1008-13. PubMed ID: 194624 [Abstract] [Full Text] [Related]
2. On the mechanisms of action of two classes of angiotensin antagonists at smooth muscle receptors. Moore GJ, Matsoukas JM, Scanlon MN, Franklin KJ, Goghari MH. Proc West Pharmacol Soc; 1984 Jul; 27():377-83. PubMed ID: 6093134 [No Abstract] [Full Text] [Related]
3. [Specific antagonism between angiotensin II and several of its analogs]. Myshliakova NV, Auna ZP, Indulen IuI, Klusha VE, Chipens GI. Probl Endokrinol (Mosk); 1976 Jul; 22(3):85-9. PubMed ID: 935097 [Abstract] [Full Text] [Related]
4. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa. De Léan A, Ong H, Gutkowska J, Schiller PW, McNicoll N. Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899 [Abstract] [Full Text] [Related]
5. On the mechanism of action of sarmesin and sarilesin at angiotensin receptors in smooth muscle. Koziarz P, Moore GJ. Proc West Pharmacol Soc; 1989 Nov; 32():79-84. PubMed ID: 2780619 [No Abstract] [Full Text] [Related]
6. [The role of G-regulatory proteins in the intracellular mechanism of cardiac angiotensin-II receptors]. Sechi LA, Sechi G, De Carli S, Griffin CA, Schambelan M, Bartoli E. Cardiologia; 1993 Aug; 38(8):519-23. PubMed ID: 8313407 [Abstract] [Full Text] [Related]
7. Specific and irreversible block of the myotropic action of angiotensin II. Escher EH, Nguyen TM, Guillemette G, Regoli DC. Nature; 1978 Sep 14; 275(5676):145-6. PubMed ID: 211425 [No Abstract] [Full Text] [Related]
9. Specific antagonists for the myotropic action of angiotensin II and angiotensin I on the isolated rat colon. Gagnon D, Park WK, Regoli D. Br J Pharmacol; 1971 Oct 14; 43(2):409-10. PubMed ID: 4333805 [Abstract] [Full Text] [Related]
12. Mechanisms and sites of action of newer angiotensin agonists and antagonists in terms of activity and receptor. Bumpus FM. Fed Proc; 1977 Jul 14; 36(8):2128-32. PubMed ID: 194800 [Abstract] [Full Text] [Related]
13. Effect of prolonged low dose infusion of angiotensin II and aldosterone on rat smooth muscle and adrenal angiotensin II receptors. Douglas JG, Brown GP. Endocrinology; 1982 Sep 14; 111(3):988-92. PubMed ID: 6286291 [No Abstract] [Full Text] [Related]
14. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. Chiu AT, McCall DE, Price WA, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PB. J Pharmacol Exp Ther; 1990 Feb 14; 252(2):711-8. PubMed ID: 2313596 [Abstract] [Full Text] [Related]